Nadda: 42 Crore Screened for NCDs at Ayushman Centres Since 2018
Synopsis
Key Takeaways
Screening 420 million people for life-threatening diseases — without a single hospital visit — is the quiet revolution happening inside India's primary healthcare network. Union Health Minister J. P. Nadda on Saturday, November 21, 2026, spotlighted a landmark milestone: since 2018, Ayushman Arogya Mandir Health and Wellness Centres have screened 42 crore Indians for hypertension, diabetes, oral cancer, breast cancer, and cervical cancer — all starting at the age of 30.
What Ayushman Arogya Mandirs Actually Do
The Ayushman Arogya Mandir network — the rebranded identity of the Health and Wellness Centres rolled out under the Ayushman Bharat programme in 2018 — was designed to push comprehensive primary care deep into sub-centre and primary health centre level. The ambition was to build a target of 1.5 lakh such centres across India, converting them from basic dispensaries into active, preventive-care nodes. Screening adults from age 30 onward is their central mandate, catching conditions before they become crises.
The five conditions covered — hypertension, diabetes, oral cancer, breast cancer, and cervical cancer — are not random choices. Non-communicable diseases now account for over 60 percent of deaths in India, and all five are both highly prevalent and highly amenable to early-stage intervention. Catching them at a sub-centre, before a patient ever queues at a district hospital, is precisely the logic the National Health Policy 2017 encoded: shift the system from curative to preventive.
The Policy Spine Behind the Numbers
The screening framework itself predates the Ayushman branding. The National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), operational since 2010, established the clinical protocols. Its guidelines were updated in 2016-17 to anchor community-based screening at the age-30 threshold, integrating it into the existing primary healthcare infrastructure rather than building a parallel, expensive vertical programme. Ayushman Bharat then gave it the network scale to actually reach hundreds of millions.
The 42 crore figure — if borne out in annual Health Ministry reporting and parliamentary disclosures — would represent one of the largest population-level NCD screening drives in the world, executed through grass-roots health infrastructure rather than mass camps or tertiary referrals.
Why Early Detection at 30 Changes the Math
The age-30 entry point is deliberate. Hypertension and Type-2 diabetes are increasingly striking Indians in their thirties and forties — younger than global averages, partly due to diet, sedentary lifestyles, and genetic predisposition. Cervical and oral cancers, meanwhile, are among the most preventable when caught in pre-cancerous stages. A screening delivered at a village-level wellness centre, free of cost, compresses the gap between silent disease and timely treatment — and keeps patients out of the catastrophic-expenditure spiral that hospitalisations trigger.
The next data point to watch: follow-up treatment rates. Screening at scale is only half the equation. Whether those flagged positive are successfully linked to care — through the broader Ayushman Bharat PM-JAY insurance framework or public facilities — will determine whether the 42 crore number translates into lives actually extended.
India has built the pipeline. The question now is how well it moves people through it.